000 01374 a2200361 4500
005 20250518004113.0
264 0 _c20190204
008 201902s 0 0 eng d
022 _a1440-1797
024 7 _a10.1111/nep.13254
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYeung, James
245 0 0 _aHigh-dose intravenous methotrexate with high-flux, extended-hours haemodialysis in treatment of primary central nervous system, post-transplant lymphoproliferative disorder and end-stage kidney disease: A case report.
_h[electronic resource]
260 _bNephrology (Carlton, Vic.)
_c11 2018
300 _a1063-1064 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aCentral Nervous System Neoplasms
_xetiology
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xtherapy
650 0 4 _aKidney Transplantation
_xadverse effects
650 0 4 _aLymphoma
_xetiology
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aRenal Dialysis
_xmethods
700 1 _aVaughan, Erin
700 1 _aChadban, Steven
700 1 _aSaunders, John
700 1 _aThiagarajah, Nisha
700 1 _aBrown, Christina
773 0 _tNephrology (Carlton, Vic.)
_gvol. 23
_gno. 11
_gp. 1063-1064
856 4 0 _uhttps://doi.org/10.1111/nep.13254
_zAvailable from publisher's website
999 _c28979435
_d28979435